The stock hit a record high of Rs 1,974, up 8%, extending its Thursday's 2% gain on the BSE in otherwise subdued market.
At 10:05 am; the was trading at Rs 422, a 2% lower against its issue price of Rs 429 per share, after listed at par on the NSE
The stock hit a 52-week high of Rs 1,260, up 3.5% on the BSE, trading close to its all-time high of Rs 1,262 touched on March 4, 2015 in intra-day trade.
Thus far in the current month, Divi's Labs outperformed the market by gaining 23% after the company on November 2, said that the USFDA will lift import alert for its Visakhapatnam unit.
The stock surged 20% to Rs 551 on the National Stock Exchange in early morning trade
Few trading ideas by Vaishali Parekh, Research Analyst - Technical Research at Prabhudas Lilladher
Derivative Strategy on Tata Elxsi by Devarsh Vakil & Nandish Shah - PCG Desk, HDFC securities
Rating downgrades still outpace upgrades
In the past one year, the number of registered clients on the BSE has shown a growth of 12.4% on an all-India basis
Opt for branded homes where the brand gets involved in the entire development process
Growth recovery in key businesses will boost revenues and margins
Key triggers are in improvement in ex-Taro performance, resolution of US FDA issues
In March, the Irdai issued a stewardship code for companies in its ambit
Poor post-listing performance of insurance firms impacted small investors' sentiments towards the IPO: Market players
Market regulator had penalised Rupani HUF, 21 other entities for manipulative trading
This Childrens Day, the UNICEF is inviting children around the world to take the centre stage in a week-long activity
The exchange said that it will provide in due course details regarding actions for non-compliance
All that happened in the market today
ITD Cementation, Larsen & Toubro Infotech, Rain Industries and Indian Bank were among 15 stocks from the S&P BSE 500 index hitting their respective new highs on the BSE in otherwise subdued market.
The benchmark stock indices overcame the initial shock to deliver robust returns in the first year after the announcement of the note-ban move